AI Models and New Lung Center Herald Personalized Era for COPD Care
Published on 07/16/2026 at 17:51 | Redaktion boerse-global.de
On the first of July 2026, a new specialized facility opened in Hanover: the Niedersächsische Lungen-Thorax-Centrum (LTC), established through a cooperation between the Klinikum Region Hannover and the Medical University of Hanover (MHH). Among the largest dedicated lung units in Germany, it is designed to bundle care for patients with respiratory conditions. The move reflects a broader shift toward individualized treatment for chronic obstructive pulmonary disease (COPD) – a trend that now extends from drug therapies to nutrition, digital tools, and even lunar dust research.
That personalization is increasingly data-driven. Researchers at the University of Koblenz have developed an artificial intelligence method that simulates treatment outcomes for individual patients. The technology, presented at a symposium in Marburg in early July, aims to fine-tune the dosage and timing of therapies based on a person’s specific disease trajectory. The Marburg meeting also focused on AI-powered image analysis and biomarker identification.
The push for tailored therapies comes as results from two large phase 3 trials on the drug Itepekimab were unveiled at a conference in Orlando in May. In the AERIFY-1 study, 1,127 former smokers with COPD received 300 mg of the antibody every two weeks. That group experienced 27.1% fewer moderate to severe exacerbations compared with placebo. A four-week dosing schedule produced a 20.5% reduction. However, the parallel AERIFY-2 trial, involving 953 participants, failed to reproduce the effect – showing no statistically significant difference between the drug and control groups.
Personalized approaches are also reaching the metabolic side of COPD care. The MHH is developing a separate AI-based tool to generate custom nutritional recommendations for chronic lung patients. The five-year project receives €1.8 million in funding. Experts expect that tailored eating strategies could improve overall physical resilience in people living with COPD.
Two smaller research threads add context. A team at University Medicine Magdeburg used a 3D model of human bronchi to test the effect of sharp-edged dust – using a lunar dust simulant. Within 72 hours, the frequency of ciliary beating dropped from 10.17 Hz to 7.18 Hz, accompanied by increased mucus production and clear cellular stress. Meanwhile, a meta-analysis of 111 studies confirmed that rhinoviruses are present in about 59% of acute asthma attacks in children and 50% in adults – findings that help clarify triggers for COPD patients as well.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
